Showing results (2401-2410 of 2,690) with videos related to
Sort By:
Pageof 269
International Forum of Allergy & Rhinology|February 12, 2024
Patient perspectives on chronic rhinosinusitis in cystic fibrosis: Symptom prioritization in the era of highly effective modulator therapyChristine M Liu, Ethan J Han, Jakob L Fischer, et al.Blood|January 25, 2013
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program StudyShimin Hu, Zijun Y Xu-Monette, Aarthi Balasubramanyam, et al.International Forum of Allergy & Rhinology|July 5, 2024
Impact of sociodemographic status and sex on chronic rhinosinusitis and olfaction in people with cystic fibrosisEthan J Han, Christine M Liu, Jakob L Fischer, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 14, 2018
CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC studyX Zhang, J Zhou, D-D Zhu, et al.Oncotarget|June 24, 2015
Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?Chi Young Ok, Qing Ye, Ling Li, et al.Human Gene Therapy|June 28, 2001
Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I studyW K Kang, C Park, H L Yoon, et al.International Forum of Allergy & Rhinology|December 25, 2023
Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapyJessa E Miller, Jennifer L Taylor-Cousar, Jonathan B Overdevest, et al.JAMA Oncology|February 7, 2020
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed GlioblastomaAnnette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, et al.European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectumCornelis J H van de Velde, Petra G Boelens, Josep M Borras, et al.Blood Cancer Journal|July 17, 2025
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphomaWenyu Shi, Zijun Y Xu-Monette, Youchao Jia, et al.Pageof 269